Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine
Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine
Active, not recruiting · NCT03836040 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine | Headache, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Active, not recruiting | Phase 3 | 2026-09-21 | NCT03836040 |
2 results · Page 1 of 1
119 results · Page 1 of 5
Research sites
Swipe the table sideways for more columns.